Mutational processes molding the genomes of 21 breast cancers.

Cancer genome landscapes. Science (2013) 25.33

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16

A landscape of driver mutations in melanoma. Cell (2012) 12.61

The life history of 21 breast cancers. Cell (2012) 10.59

Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol (2013) 7.97

APOBEC3B is an enzymatic source of mutation in breast cancer. Nature (2013) 5.18

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet (2013) 4.69

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science (2014) 4.28

Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet (2013) 4.03

Whole genomes redefine the mutational landscape of pancreatic cancer. Nature (2015) 4.01

Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet (2013) 3.96

Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet (2013) 3.94

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet (2014) 3.75

Deciphering signatures of mutational processes operative in human cancer. Cell Rep (2013) 3.61

Intratumor heterogeneity: evolution through space and time. Cancer Res (2012) 3.45

Evolution of the cancer genome. Nat Rev Genet (2012) 3.24

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun (2014) 3.12

Whole-genome characterization of chemoresistant ovarian cancer. Nature (2015) 3.06

Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature (2016) 3.05

Integrative annotation of variants from 1092 humans: application to cancer genomics. Science (2013) 2.98

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet (2014) 2.72

DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife (2013) 2.67

Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage. Science (2014) 2.58

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet (2013) 2.53

Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet (2013) 2.42

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol (2013) 2.35

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet (2015) 2.29

Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med (2015) 2.29

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep (2014) 2.27

The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell (2014) 2.21

Visualizing multidimensional cancer genomics data. Genome Med (2013) 2.19

Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat Rev Cancer (2012) 2.17

Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet (2014) 2.11

Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat Genet (2015) 2.10

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A (2013) 2.00

Clock-like mutational processes in human somatic cells. Nat Genet (2015) 1.91

Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma. Nat Genet (2015) 1.89

Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res (2012) 1.82

Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res (2013) 1.77

High-throughput sequencing for biology and medicine. Mol Syst Biol (2013) 1.75

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science (2014) 1.74

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nat Genet (2014) 1.68

The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell (2013) 1.68

Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection. Nat Methods (2015) 1.67

Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer (2014) 1.67

Genome-wide patterns and properties of de novo mutations in humans. Nat Genet (2015) 1.65

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov (2014) 1.63

Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun (2013) 1.62

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev (2013) 1.62

Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev (2013) 1.61

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood (2013) 1.60

Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet (2014) 1.60

B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell (2014) 1.58

The mutational landscapes of genetic and chemical models of Kras-driven lung cancer. Nature (2014) 1.57

Cancer genome-sequencing study design. Nat Rev Genet (2013) 1.55

The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol (2013) 1.54

Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A (2013) 1.54

Identity and function of a large gene network underlying mutagenic repair of DNA breaks. Science (2012) 1.52

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Cancer Discov (2015) 1.51

Chromothripsis and Kataegis Induced by Telomere Crisis. Cell (2015) 1.49

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun (2015) 1.49

Genome sequencing of normal cells reveals developmental lineages and mutational processes. Nature (2014) 1.48

The Complete Genome Sequences, Unique Mutational Spectra, and Developmental Potency of Adult Neurons Revealed by Cloning. Neuron (2016) 1.48

The APOBEC3 family of retroelement restriction factors. Curr Top Microbiol Immunol (2013) 1.46

High-definition reconstruction of clonal composition in cancer. Cell Rep (2014) 1.45

Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol (2014) 1.44

Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat Commun (2014) 1.42

Recurrent and functional regulatory mutations in breast cancer. Nature (2017) 1.39

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer. Elife (2014) 1.39

BRCAness revisited. Nat Rev Cancer (2016) 1.38

Genome evolution during progression to breast cancer. Genome Res (2013) 1.37

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol Med (2015) 1.37

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A (2014) 1.36

A common deletion in the APOBEC3 genes and breast cancer risk. J Natl Cancer Inst (2013) 1.36

Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36

AID/APOBEC cytosine deaminase induces genome-wide kataegis. Biol Direct (2012) 1.36

Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Oncogene (2013) 1.33

Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine. Genome Med (2014) 1.31

The topography of mutational processes in breast cancer genomes. Nat Commun (2016) 1.30

Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue. Genome Biol (2013) 1.29

An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet (2015) 1.29

Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet (2015) 1.28

Engineered proteins detect spontaneous DNA breakage in human and bacterial cells. Elife (2013) 1.28

APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis (2013) 1.27

APOBEC3A functions as a restriction factor of human papillomavirus. J Virol (2014) 1.24

BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies. Genome Biol (2015) 1.22

Base damage within single-strand DNA underlies in vivo hypermutability induced by a ubiquitous environmental agent. PLoS Genet (2012) 1.22

Polymerase theta-mediated end joining of replication-associated DNA breaks in C. elegans. Genome Res (2014) 1.22

Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol (2015) 1.22

Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair. Nat Biotechnol (2013) 1.21

C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. Genome Res (2014) 1.21

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome. Cell Rep (2015) 1.21

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol (2014) 1.19

APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation. Proc Natl Acad Sci U S A (2015) 1.19

Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers. Breast Cancer Res (2014) 1.18

Performance of common analysis methods for detecting low-frequency single nucleotide variants in targeted next-generation sequence data. J Mol Diagn (2013) 1.17

Inferring clonal composition from multiple sections of a breast cancer. PLoS Comput Biol (2014) 1.17

Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94

Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res (2008) 151.16

Molecular portraits of human breast tumours. Nature (2000) 94.14

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63

Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13

Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09

Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med (2009) 24.75

A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27

The cancer genome. Nature (2009) 23.13

Learning the parts of objects by non-negative matrix factorization. Nature (1999) 21.77

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature (2002) 21.53

International network of cancer genome projects. Nature (2010) 20.35

Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68

A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08

Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28

Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72

Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics (2009) 15.08

The genomic complexity of primary human prostate cancer. Nature (2011) 14.06

Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature (2009) 13.45

The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24

The life history of 21 breast cancers. Cell (2012) 10.59

Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci U S A (2004) 10.47

Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G+C)-biased genomes. Nat Methods (2009) 10.41

The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature (2010) 10.04

Signatures of mutation and selection in the cancer genome. Nature (2010) 9.75

Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A (2010) 7.70

Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene (2002) 7.04

Transcription-coupled DNA repair: two decades of progress and surprises. Nat Rev Mol Cell Biol (2008) 7.00

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet (2005) 6.70

Exploring the genomes of cancer cells: progress and promise. Science (2011) 6.16

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell (2002) 5.14

Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature (2003) 4.84

Mutations induced by ultraviolet light. Mutat Res (2005) 4.45

Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80

APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol (2010) 3.61

Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science (1993) 3.52

Origin of chromosomal translocations in lymphoid cancer. Cell (2010) 2.94

Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A (1995) 2.80

Increased mutagenesis and unique mutation signature associated with mitotic gene conversion. Science (2010) 2.72

Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis (2001) 2.66

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J Virol (2011) 2.50

AID in somatic hypermutation and class switch recombination. Curr Opin Immunol (2006) 2.48

Break-induced replication is highly inaccurate. PLoS Biol (2011) 2.45

The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst) (2006) 2.43

Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice. J Exp Med (2006) 2.10

APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep (2011) 2.07

Evidence for mutation showers. Proc Natl Acad Sci U S A (2007) 2.00

Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc Natl Acad Sci U S A (2011) 1.98

The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. Mol Immunol (2005) 1.78

TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours. Int J Cancer (2009) 1.52

Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol (2011) 1.31

The molecular pathology of hereditary breast cancer. Pathobiology (2008) 1.25

Thymine-DNA glycosylase and G to A transition mutations at CpG sites. Mutat Res (2000) 1.24

Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis (1997) 1.15

Transient hypermutability, chromothripsis and replication-based mechanisms in the generation of concurrent clustered mutations. Mutat Res (2012) 1.05

Oxidative DNA damage following microsome/Cu(II)-mediated activation of the estrogens, 17β-estradiol, equilenin, and equilin: role of reactive oxygen species. Chem Res Toxicol (2012) 0.98

Mutagenicity of secondary oxidation products of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-hydroxy-2'- deoxyguanosine 5'-triphosphate). Mutat Res (2011) 0.92

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

Mutations of the BRAF gene in human cancer. Nature (2002) 65.42

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet (2008) 43.63

Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41

A census of human cancer genes. Nat Rev Cancer (2004) 36.20

Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A (2003) 34.68

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

A high-resolution recombination map of the human genome. Nat Genet (2002) 28.66

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med (2009) 24.75

A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27

The cancer genome. Nature (2009) 23.13

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47

International network of cancer genome projects. Nature (2010) 20.35

High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet (2008) 19.97

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet (2005) 18.59

A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39